{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T23:40:05Z","timestamp":1750376405336,"version":"3.41.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nmd.2025.105392","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T15:04:38Z","timestamp":1747494278000},"page":"105392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A systematic review on motor outcome measures in congenital myopathy"],"prefix":"10.1016","volume":"51","author":[{"given":"Matthew","family":"Woods","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Lilien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-4061","authenticated-orcid":false,"given":"Laurent","family":"Servais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.105392_bib0001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1186\/s12967-024-05626-5","article-title":"Congenital myopathies: pathophysiological mechanisms and promising therapies","volume":"22","author":"Zhang","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.nmd.2025.105392_bib0002","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/B978-0-323-98818-6.00027-3","article-title":"Congenital myopathies","volume":"195","author":"Younger","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.761636","article-title":"A Systematic Review and Meta-Analysis of the Prevalence of Congenital Myopathy","volume":"12","author":"Huang","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13052-017-0419-z","article-title":"Congenital myopathies: clinical phenotypes and new diagnostic tools","volume":"43","author":"Cassandrini","year":"2017","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.nmd.2025.105392_bib0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/14728222.2022.2157258","article-title":"Early clinical and pre-clinical therapy development in Nemaline myopathy","volume":"26","author":"Fisher","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.nmd.2025.105392_bib0006","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.nmd.2021.08.015","article-title":"A review of core myopathy: central core disease, multiminicore disease, dusty core disease, and core-rod myopathy","volume":"31","author":"Ogasawara","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-2-25","article-title":"Central core disease","volume":"2","author":"Jungbluth","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111377","article-title":"Common pathogenic mechanisms in centronuclear and myotubular myopathies and latest treatment advances","volume":"22","author":"G\u00f3mez-Oca","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2025.105392_bib0009","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/cge.14054","article-title":"Clinical, genetic, and histological features of centronuclear myopathy in The Netherlands","volume":"100","author":"Reumers","year":"2021","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2025.105392_bib0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.spen.2011.10.008","article-title":"Congenital fiber-type disproportion","volume":"18","author":"Clarke","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103694","article-title":"Update on congenital myopathies in adulthood","volume":"21","author":"Papadimas","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2025.105392_bib0012","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/08830738221096316","article-title":"Pediatric nemaline myopathy: a systematic review using individual patient data","volume":"37","author":"Christophers","year":"2022","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2025.105338","article-title":"The widening genetic and myopathologic spectrum of congenital myopathies (CMYOs): a narrative review","volume":"49","author":"Onn\u00e9e","year":"2025","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0014","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3349\/ymj.2006.47.4.513","article-title":"Comparison of clinical characteristics between congenital fiber type disproportion myopathy and congenital myopathy with type 1 fiber predominance","volume":"47","author":"Na","year":"2006","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.nmd.2025.105392_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70109","article-title":"Disease trajectories of a large french cohort of 142 congenital myopathy patients in adult age","volume":"32","author":"Bisciglia","year":"2025","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nmd.2022.02.009","article-title":"Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls","volume":"32","author":"Muntoni","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201004","article-title":"Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study","volume":"13","author":"Chabanon","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.105392_bib0018","doi-asserted-by":"crossref","first-page":"e3331","DOI":"10.1002\/brb3.3331","article-title":"Natural history of Duchenne muscular dystrophy in the United Kingdom: a descriptive study using the Clinical Practice Research Datalink","volume":"13","author":"Broomfield","year":"2023","journal-title":"Brain Behav"},{"key":"10.1016\/j.nmd.2025.105392_bib0019","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/acn3.51281","article-title":"Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study","volume":"8","author":"Annoussamy","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ana.25101","article-title":"Natural history of infantile-onset spinal muscular atrophy","volume":"82","author":"Kolb","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0021","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0883073812436605","article-title":"Consensus statement on standard of care for congenital myopathies","volume":"27","author":"Wang","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0024","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.nmd.2020.08.356","article-title":"250th ENMC International Workshop: clinical trial readiness in nemaline myopathy 6-8 September 2019, Hoofdorp, The Netherlands","volume":"30","author":"Neuhaus","year":"2020","journal-title":"Neuromuscul Disord"},{"author":"JPT Higgins","key":"10.1016\/j.nmd.2025.105392_bib0025"},{"key":"10.1016\/j.nmd.2025.105392_bib0026","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.nmd.2025.105392_bib0027","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s13023-022-02527-y","article-title":"Rare disease education in Europe and beyond: time to act","volume":"17","author":"Tumiene","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0029","article-title":"A patient-centered evaluation of meaningful change on the 32-item motor function measure in spinal muscular atrophy using qualitative and quantitative data","volume":"12","author":"Duong","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0030","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1111\/ene.14472","article-title":"Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy","volume":"27","author":"Stolte","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283669","article-title":"Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy","volume":"18","author":"Ayyar Gupta","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.105392_bib0032","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JND-210646","article-title":"The minimal clinical important difference (MCID) in annual rate of change of timed function tests in boys with DMD","volume":"8","author":"Duong","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0033","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.20179","article-title":"Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies","volume":"50","author":"Huber","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nmd.2025.105392_bib0034","article-title":"Minimal clinically important differences in motor function in patients with infantile-onset spinal muscular atrophy: results from the Phase 3 ENDEAR trial","volume":"23","author":"Stull","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.nmd.2025.105392_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18052314","article-title":"Responsiveness and minimal clinically important difference of the five times sit-to-stand test in patients with stroke","volume":"18","author":"Agust\u00edn","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.nmd.2025.105392_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272858","article-title":"Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): observations from a phase 2 trial","volume":"17","author":"Muntoni","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.105392_bib0037","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","article-title":"The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation","volume":"7","author":"Main","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0038","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JND-230001","article-title":"Psychometric characteristics of the motor function measure in neuromuscular diseases: a systematic review1","volume":"10","author":"Ribault","year":"2023","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0039","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1474-4422(23)00313-7","article-title":"Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial","volume":"22","author":"Shieh","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0040","doi-asserted-by":"crossref","first-page":"e1852","DOI":"10.1212\/WNL.0000000000007319","article-title":"X-linked myotubular myopathy: a prospective international natural history study","volume":"92","author":"Annoussamy","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105392_bib0041","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s00415-018-9033-2","article-title":"Correlation of phenotype with genotype and protein structure in RYR1-related disorders","volume":"265","author":"Todd","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0042","doi-asserted-by":"crossref","unstructured":"Todd J., Lawal T., Chrismer I., Kokkinis A., Grunseich C., Jain M., et al. Rycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial. 2024;68.","DOI":"10.1016\/j.eclinm.2024.102433"},{"key":"10.1016\/j.nmd.2025.105392_bib0043","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejpn.2023.11.005","article-title":"Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study","volume":"48","author":"Bouman","year":"2024","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2025.105392_bib0044","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3233\/JND-200574","article-title":"Progression or Not - a small natural history study of genetical confirmed congenital myopathies","volume":"8","author":"Werlauff","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JND-200549","article-title":"Ryanodine receptor 1-related myopathies: quantification of intramuscular fatty infiltration from T1-Weighted MRI","volume":"8","author":"Lawal","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0046","doi-asserted-by":"crossref","first-page":"e1495","DOI":"10.1212\/WNL.0000000000207723","article-title":"Long-term natural history of pediatric dominant and recessive RYR1-related myopathy","volume":"101","author":"Sarkozy","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105392_bib0047","doi-asserted-by":"crossref","first-page":"e1425","DOI":"10.1212\/WNL.0000000000011458","article-title":"A Cross-Sectional Study of Nemaline Myopathy","volume":"96","author":"Amburgey","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105392_bib0048","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.nmd.2022.07.398","article-title":"Feasibility, safety, and efficacy of 12-week side-to-side vibration therapy in children and adolescents with congenital myopathy in New Zealand","volume":"32","author":"Adaikina","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0049","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.nmd.2022.06.009","article-title":"Respiratory muscle function in patients with nemaline myopathy","volume":"32","author":"van Kleef","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JND-210781","article-title":"INCEPTUS natural history, run-in study for gene replacement clinical trial in X-linked myotubular myopathy","volume":"9","author":"Dowling","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0051","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/mus.26491","article-title":"Motor function performance in individuals with RYR1-related myopathies","volume":"60","author":"Witherspoon","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105392_bib0052","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0300060516674608","article-title":"Reliability of home-based, motor function measure in hereditary neuromuscular diseases","volume":"45","author":"Ruiz-Cortes","year":"2017","journal-title":"J Int Med Res"},{"key":"10.1016\/j.nmd.2025.105392_bib0053","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JND-140040","article-title":"Frequency and phenotype of myotubular myopathy amongst danish patients with congenital myopathy older than 5 Years","volume":"2","author":"Werlauff","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0054","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.apmr.2014.06.005","article-title":"Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy","volume":"95","author":"Vuillerot","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2025.105392_bib0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","article-title":"The MFMCSG. A motor function measure scale for neuromuscular diseases. Construction and validation study","volume":"15","author":"B\u00e9rard","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0056","doi-asserted-by":"crossref","first-page":"e1852","DOI":"10.1212\/WNL.0000000000007319","article-title":"X-linked myotubular myopathy: a prospective international natural history study","volume":"92","author":"Annoussamy","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105392_bib0057","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.nmd.2010.06.014","article-title":"North star ambulatory assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy","volume":"20","author":"Mazzone","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0058","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X211008725","article-title":"Spinal muscular atrophy: the use of functional motor scales in the era of disease-modifying treatment","volume":"8","author":"Pierzchlewicz","year":"2021","journal-title":"Child Neurol Open"},{"key":"10.1016\/j.nmd.2025.105392_bib0059","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2004-821173","article-title":"Pilot trial of salbutamol in central core and multi-minicore diseases","volume":"35","author":"Messina","year":"2004","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2025.105392_bib0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13023-021-01928-9","article-title":"Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001)","volume":"16","author":"Nakajima","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 3","key":"10.1016\/j.nmd.2025.105392_bib0061","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1007\/s10545-010-9085-7","article-title":"Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction","volume":"33","author":"Schreuder","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0062","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JND-200479","article-title":"Use of the children's hospital of philadelphia infant test of neuromuscular disorders (CHOP INTEND) in X-linked myotubular myopathy: content validity and psychometric performance","volume":"8","author":"Duong","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0063","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/13854046.2016.1216518","article-title":"Assessing developmental delay in early childhood - concerns with the Bayley-III scales","volume":"31","author":"Anderson","year":"2017","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.nmd.2025.105392_bib0064","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1177\/15648265040251S106","article-title":"Assessment of gross motor development in the WHO Multicentre Growth Reference Study","volume":"25","author":"Wijnhoven","year":"2004","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.nmd.2025.105392_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104894","article-title":"Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial","volume":"99","author":"Lawlor","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nmd.2025.105392_bib0066","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/JND-230182","article-title":"Relationship between hand strength and function in duchenne muscular dystrophy and spinal muscular atrophy: implications for clinical trials","volume":"11","author":"Decostre","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0067","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.braindev.2022.09.005","article-title":"Handgrip and finger flexion strength in children: a cross-sectional assessment of age-related normative data and application as a clinical functional marker in paediatric neuromuscular disorders","volume":"45","author":"Weber","year":"2023","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2025.105392_bib0068","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jns.12119","article-title":"Van den Bergh PY. Outcome measures in neuromuscular disease: is the world still flat?","volume":"20","author":"Lunn","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2025.105392_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146036","article-title":"Aerobic training in patients with congenital myopathy","volume":"11","author":"Hedermann","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.105392_bib0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.880140505","article-title":"The natural history of minicore-multicore myopathy","volume":"14","author":"Penegyres","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105392_bib0071","doi-asserted-by":"crossref","unstructured":"Witherspoon J., Rekant J., Wakim P., Vasavada R., Waite M., Chrismer I., et al. Use of Fatigue Index as a Measure of Local Muscle Fatigability in Ryanodine Receptor Isoform-1-Related Myopathies. 2019;10.","DOI":"10.3389\/fneur.2019.01234"},{"key":"10.1016\/j.nmd.2025.105392_bib0072","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.nmd.2020.06.007","article-title":"Contractile properties are impaired in congenital myopathies","volume":"30","author":"Eisum","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0073","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nmd.2006.05.003","article-title":"Muscle slowness in a family with nemaline myopathy","volume":"16","author":"Pauw-Gommans","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105392_bib0074","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/CS20030159","article-title":"Quadriceps weakness in a family with nemaline myopathy: influence of knee angle","volume":"105","author":"Gerrits","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.nmd.2025.105392_bib0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13023-018-0848-9","article-title":"6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies","volume":"13","author":"Witherspoon","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2025.105392_bib0077","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ajmg.a.38413","article-title":"Challenges of developing and conducting clinical trials in rare disorders","volume":"176","author":"Kempf","year":"2018","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nmd.2025.105392_bib0078","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/cpt.2247","article-title":"Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular Atrophy","volume":"110","author":"Baranello","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nmd.2025.105392_bib0079","article-title":"Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial","volume":"10","author":"Seferian","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.105392_bib0080","article-title":"Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial","volume":"10","author":"Seferian","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.105392_bib0081","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/14712598.2025.2473430","article-title":"X-linked myotubular myopathy: an untreated treatable disease","volume":"25","author":"Martin","year":"2025","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.nmd.2025.105392_bib0082","article-title":"Efficacy and safety of onasemnogene abeparvovec in children with spinal muscular atrophy type 1: real-world evidence from 6 infusion centres in the United Kingdom","volume":"37","author":"Gowda","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.nmd.2025.105392_bib0083","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamapediatrics.2024.0492","article-title":"Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: a Nonrandomized Controlled Trial","volume":"178","author":"Schwartz","year":"2024","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.nmd.2025.105392_bib0084","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/mus.27682","article-title":"Prognostic factors, disease course, and treatment efficacy in Duchenne muscular dystrophy: a systematic review and meta-analysis","volume":"66","author":"Weber","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105392_bib0085","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1038\/s41591-023-02459-5","article-title":"First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD","volume":"29","author":"Servais","year":"2023","journal-title":"Nat Med"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T23:24:38Z","timestamp":1750375478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":81,"alternative-id":["S0960896625001191"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105392","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review on motor outcome measures in congenital myopathy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105392"}}